{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:26:59Z","timestamp":1793086019530,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"publisher","award":["2066\/UN1\/KU\/PP\/PT.01.03\/2025"],"award-info":[{"award-number":["2066\/UN1\/KU\/PP\/PT.01.03\/2025"]}],"id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023692","name":"Doherty Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014555","name":"Murdoch Children&apos;s Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vaccine.2025.127872","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:42:26Z","timestamp":1761014546000},"page":"127872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Jonathan Hasian","family":"Haposan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeng Viska","family":"Icanervilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suci Ardini","family":"Widyaningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ulfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prita","family":"Widayanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Safitri","family":"Laksanawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarir","family":"At Thobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Bines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127872_bb0005","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.110008","article-title":"Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission","volume":"1","author":"Baker","year":"2011","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2025.127872_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-023-00480-z","volume":"9","author":"Meiring","year":"2023","journal-title":"Typhoid fever Nat Rev Dis Primer"},{"key":"10.1016\/j.vaccine.2025.127872_bb0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4269\/ajtmh.19-0479","article-title":"Associations among Water, Sanitation, and Hygiene, and Food Exposures and Typhoid Fever in Case\u2013Control Studies: A Systematic Review and Meta-Analysis","volume":"103","author":"Brockett","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127872_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the global burden of disease study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1186\/s12879-025-11223-8","article-title":"The global burden of typhoid and paratyphoid fever from 1990 to 2021 and the impact on prevention and control","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0030","author":"Murthy","year":"2025","journal-title":"Global typhoid fever incidence: an updated systematic review with meta-analysis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, march 2018\u2013recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163511","article-title":"Development of an acid-resistant Salmonella typhi Ty21a attenuated vector for improved Oral vaccine delivery","volume":"11","author":"Dharmasena","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127872_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/erv.10.43","article-title":"Population impact of vi capsular polysaccharide vaccine","volume":"9","author":"Khan","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127872_bb0050","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0055","series-title":"Immunogenicity and efficacy of conjugated and unconjugated vi-polysaccharide vaccines in the prevention of typhoid fever","author":"Jin","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127872_bb0060","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127872_bb0065","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S2214-109X(23)00606-X","article-title":"Efficacy of typhoid vaccines against culture-confirmed Salmonella typhi in typhoid endemic countries: a systematic review and meta-analysis","volume":"12","author":"Batool","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127872_bb0070","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127872_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013067","article-title":"XDR typhoid in Pakistan: a threat to global health security and a wake-up call for antimicrobial stewardship","volume":"19","author":"Abdullah","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0085","article-title":"Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)","volume":"2023","author":"Gloeck","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.127872_bb0110","first-page":"372","article-title":"statement: an updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2025.127872_bb0125","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.vaccine.2022.04.093","article-title":"Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study","volume":"40","author":"Lightowler","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0130","article-title":"Extensively drug-resistant typhoid fever in the United States. Open forum","volume":"8","author":"Hughes","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2025.127872_bb0135","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127872_bb0145","first-page":"355","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2025.127872_bb0155","author":"Deeks"},{"key":"10.1016\/j.vaccine.2025.127872_bb0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13063-023-07555-y","article-title":"An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban south Indian cohort","volume":"24","author":"Sahai","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2025.127872_bb0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/vaccines9030281","article-title":"Evaluation of typhoid conjugate vaccine effectiveness in Ghana (TyVEGHA) using a cluster-randomized controlled phase IV trial: trial design and population baseline characteristics","volume":"9","author":"Haselbeck","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127872_bb0175","author":"Khanam"},{"key":"10.1016\/j.vaccine.2025.127872_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(25)00056-7","article-title":"The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial","author":"Feng","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127872_bb0185","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(24)01494-6","article-title":"5-year vaccine protection following a single dose of vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial","volume":"404","author":"Qadri","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127872_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101925","article-title":"Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis","volume":"58","author":"Khanam","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0195","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127872_bb0200","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2214-109X(22)00466-1","article-title":"Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data","volume":"11","author":"Liang","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127872_bb0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cid\/ciad132","article-title":"Programmatic effectiveness of a pediatric typhoid conjugate vaccine campaign in Navi Mumbai","volume":"77","author":"Hoffman","year":"2023","journal-title":"India Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2025.127872_bb0210","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1016\/j.vaccine.2022.06.072","article-title":"Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh","volume":"40","author":"Thobani","year":"2022","journal-title":"Pakistan Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0215","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.24-0181","article-title":"Field effectiveness of a typhoid conjugate vaccine: The 2018 Navi Mumbai Pediatric TCV campaign","author":"Date","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127872_bb0220","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2021.08.051","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: a case-control study","volume":"39","author":"Batool","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0225","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ofid\/ofad042","article-title":"Progress in the typhoid conjugate vaccine program rollout supported by Gavi during the COVID-19 pandemic and the path forward","volume":"10","author":"Russell","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0230","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1038\/s41467-023-42353-9","article-title":"Assessing the global risk of typhoid outbreaks caused by extensively drug resistant Salmonella typhi","volume":"14","author":"Walker","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127872_bb0235","first-page":"1","article-title":"Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use","author":"World Health, others","year":"2024","journal-title":"World health Organ"},{"key":"10.1016\/j.vaccine.2025.127872_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study","volume":"22","author":"Birger","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0245","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1186\/s12879-021-06599-2","article-title":"A review of clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant (XDR) Salmonella typhi isolates in children in Karachi","volume":"21","author":"Shahid","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and Southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0255","first-page":"27","article-title":"Safety and immunogenicity of vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study","author":"Capeding","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0260","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/cid\/ciy386","article-title":"Determining the best immunization strategy for protecting African children against invasive Salmonella disease","volume":"67","author":"Jeon","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127872_bb0265","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3855\/jidc.1048","article-title":"Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009","volume":"4","author":"Podda","year":"2010","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2025.127872_bb0270","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S2214-109X(24)00055-X","article-title":"Typhoid conjugate vaccines: a step towards typhoid control","volume":"12","author":"Shakya","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127872_bb0275","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/cer-2020-0228","article-title":"Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance","volume":"10","author":"Jaksa","year":"2021","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.vaccine.2025.127872_bb0280","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.vaccine.2021.04.032","article-title":"Pertussis vaccine effectiveness and duration of protection \u2013 a systematic review and meta-analysis","volume":"39","author":"Wilkinson","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127872_bb0290","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127872_bb0295","series-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever Report from a meeting held on 26-27 October 2016, Oxfor","first-page":"5081","volume":"35","author":"Meiring","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127872_bb0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/EDE.0000000000001116","article-title":"The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology","volume":"31","author":"Chua","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2025.127872_bb0305","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1586\/14760584.2014.930666","article-title":"Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic","volume":"13","author":"Minodier","year":"2014","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:00:03Z","timestamp":1773190803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25011697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"alternative-id":["S0264410X25011697"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127872","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127872"}}